Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Orchid Medical Centre Keeps Its Neurology Department Running Around the Clock for Ranchi PatientsOrchid Medical Centre is a NABH- and NABL-accredited super speciality hospital in Ranchi, Jharkhand
- Miller Children’s & Women’s HospitalMiller Children's & Women's Hospital Performs First Minima Stent Procedure for Infants with Congenital Heart ConditionsFirst FDA-approved stent designed specifically for the smallest patients with certain congenital heart and vascular conditions. — The Children's Heart Institute at Miller Children's & Women's Hospital has successfully performed the Renata...
- Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that on September 14, 2026, the Compensation Committee of the Company’s Board of Directors granted 2,747,385 restricted stock units (the “RSUs”) to Simeon Kohl under the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan (the “Inducement Plan”) in connection with Mr. Kohl’s previously announced appointment as Chief Executive Officer and President of the Company effective on September 14, 2026. The awards were granted as inducement material to Mr. Kohl’s entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- Ascendis PharmaAscendis Announces Planned $400 Million Share Repurchase ProgramAscendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to repurchase up to $400 million of the Company’s ordinary shares (the Share Repurchase Program).
- Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising AwardsNational recognition honors Onspire client work spanning digital experience, recruitment, advertising and integrated marketing
- ReDEFYReDEFY Launches "Built Before the Meeting:" California's Environmental Health Agencies Get a Working Salesforce Solution Ahead of the CERS NextGen DeadlineCompanies: SalesforceAt Dreamforce 2026, ReDEFY, a Salesforce consulting partner, arrives having already built Environmental Health solutions for California county governments ahead of the state's CERS NextGen deadline. — With Dreamforce 2026 opening next week in San...
- Veea Inc. and NovaGen announce potential merger to launch an Edge AI-Powered Global Health PlatformVeea and NovaGen announce a potential merger and an edge AI-powered health platform, with a US$10 million investment commitment from GeoNova Capital.
- DLH Holdings Corp.DLH Appoints Brooke Pierce President of Health Business GroupDLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that Brooke Pierce has been appointed President, Health, effective September 14, 2026.
- Endpoint ClinicalEndpoint Clinical Acquires Bluefin, a Provider of Clinical Supply Forecasting and Planning TechnologyThis acquisition expands Endpoint into clinical supply planning while keeping Bluefin independent and RTSM-agnostic. — Endpoint Clinical L.P., a global leader in randomization and trial supply management ("RTSM") solutions and a...
- Mercy Medical CenterMercy Medical Center Among First in the Mid-Atlantic to Offer Mako SmartRobotics™ Technology for Shoulder Replacement SurgeryDr. Gregory Gasbarro Leads Introduction of Advanced Robotic-Arm Assisted Shoulder Arthroplasty at Mercy — Mercy Medical Center is advancing orthopedic care in the Mid-Atlantic region with the introduction of Mako SmartRobotics™ technology for...
- DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health pathologies using Artificial Intelligence (AI) techniques, announces that the 2026 annual general meeting of shareholders (the “Meeting”) will be held on September 30, 2026, at 10:00 a.m., in person, at Alt Quartier DIX30 Hotel, 6500 de Rome Blvd, 2nd floor, Brossard, QC, J4Y 0B6, for the following purposes:
- GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLFGENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF